Article
Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps.
Immunity - 19 May 2015
Mitra Suman, Ring Aaron M, Amarnath Shoba, Spangler Jamie B, Li Peng, Ju Wei, Fischer Suzanne, Oh Jangsuk, Spolski Rosanne, Weiskopf Kipp, Kohrt Holbrook, Foley Jason E, Rajagopalan Sumati, Long Eric O, Fowler Daniel H, Waldmann Thomas A, Garcia K Christopher, Leonard Warren J
Abstract excerpt
Interleukin-2 (IL-2) regulates lymphocyte function by signaling through heterodimerization of the IL-2Rβ and γc receptor subunits. IL-2 is of considerable therapeutic interest, but harnessing its actions in a controllable manner remains a challenge. Previously, we have engineered an IL-2 "superkine" with enhanced affinity for IL-2Rβ. Here, we describe next-generation IL-2 variants that function as "receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
